Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

0(0%)

Results Posted

71%(5 trials)

Phase Distribution

Ph not_applicable

86%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 4Post-market surveillance

1(14.3%)

N/ANon-phased studies

6(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (14.3%)

N/A6 (85.7%)

Trials by Status

completed7100%

Recent Activity

0 active trials

Showing 5 of 7

completednot_applicable

The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction

NCT01207752

completednot_applicable

The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance

NCT00673764

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT01207752Not Applicable

The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction

Completed

NCT00673764Not Applicable

The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance

Completed

NCT00848068Not Applicable

Evaluation of FID 114657 on Tear Film Lipid Layer Thickness

Completed

NCT00756093Not Applicable

Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops

Completed

NCT00673855Not Applicable

Acute Comfort of Lubricant Eye Drops FID 112903

Completed

NCT00568386Not Applicable

Acute Comfort and Blur of Systane and Optive

Completed

NCT01051804Phase 4

Evaluation of the Repeated Usage of Systane Ultra Eyedrop

Completed

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7